Case Report
References
Akizuki M, Homma M (1991). "Amelioration of secondary hypertrophic osteoarthropathy following tumor resection in a patient with primary lung cancer." Ryūmachi (Rheumatism) 31(3):311-316. |
||||
Amital H, Applbaum YH, Vasiliev L, Rubinow A (2004). "Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate." Clin. Rheumatol. 23(4):330-332. |
||||
Angel-Moreno Maroto A, Martínez-Quintana E, Suárez-Castellano L, Pérez-Arellano JL (2005). "Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF)." Rheumatology (Oxford, England) 44(10):1326-1327. Crossref |
||||
Atkinson S, Fox SB (2004). "Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing." J. Pathol. 203(2):721-728. Crossref |
||||
Bazar KA, Yun AJ, Lee PY (2004). "Hypertrophic osteoarthropathy may be a marker of underlying sympathetic bias." Med. hypotheses 63(2):357-361. Crossref |
||||
Dickinson CJ, Martin JF (1987). "Megakaryocytes and platelet clumps as the cause of finger clubbing." Lancet 2(8573):1434-1435. |
||||
Garske LA, Bell SC (2002). "Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis." Chest 121(4):1363-1364. Crossref |
||||
Hara Y, Matsuura Y, Takiguchi H, Ameku K, Numakura T, Horie T, Minowa M, Matsumura Y (2010). "Reversal of pulmonary hypertrophic osteoarthropathy in surgically treated lung cancer." Nihon Kokyuki Gakkai Zasshi 48(12):966-971. |
||||
Hayashi M, Sekikawa A, Saijo A, Takada W, Yamawaki I, Ohkawa S (2005). "Successful treatment of hypertrophic osteoarthropathy by gefitinib in a case with lung adenocarcinoma." Anticancer Res. 25(3c):2435-2438. |
||||
Johnson SA, Spiller PA, Faull CM (1997). "Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide." Thorax 52(3):298-299. Crossref |
||||
King MM, Nelson DA (2008). "Hypertrophic osteoarthropathy effectively treated with zoledronic acid." Clin. Lung Cancer. 9(3):179-82. Crossref |
||||
Kozak KR, Milne GL, Morrow JD, Cuiffo BP (2006). "Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2." Nat. Clin. Pract. Rheumatol. 2(8):452-456. |
||||
Nguyen S, Hojjati M (2011). "Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy." Clin. Rheumatol. 30(1):7-13. Crossref |
||||
Ntaios G, Alexandra A, Dimitrios K (2008). "Hypertrophic pulmonary osteoarthropathy secondary to bronchial adenocarcinoma and coexisting pulmonary tuberculosis: a case report." Cases J. 1(1):221. |
||||
Olán F, Portela M, Navarro C, Gaxiola M, Silveira LH, Ruiz V, Martínez-Lavín M (2004). "Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity." J. Rheumatol. 31(3):614-616. |
||||
Ooi A, Saad RA, Moorjani N, Amer KM (2007). "Effective symptomatic relief of hypertrophic pulmonary osteoarthropathy by video-assisted thoracic surgery truncal vagotomy." Ann. Thorac. Surg. 83(2):684-685. Pubmed |
||||
Speden D, Nicklason F, Francis H, Ward J (1997). "The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA)." Austr. N. Z. J. Med. 27(3):307-310. |
||||
Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Yoshimasu T, Naito Y (2001). "Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma." Anti-cancer Drugs. 12(9):731-734. Pubmed |
||||
Towler DA (2007). "Vascular biology and bone formation: hints from HIF." J. Clin. Investig. 117(6):1477-80. Crossref |
||||
Yao Q, Altman RD, Brahn E (2009). "Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature." Semin. Arthritis Rheum. 38(6):458-466. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0